PALI

Palisade Bio, Inc.$2.02+0.09 (+4.66%)

Prev Close$1.93·MCap$342.0M·P/E—·Vol2.19M·Yield—

▲

Buys (12M)

$276.3K

▼

Sells (12M)

$420.2K

◆

Net Activity

Net Seller

$143.9K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Palisade Bio, Inc. (PALI) has been mixed between buying and selling, with 6 insider purchases totaling $276.3K and 4 insider sales totaling $420.2K. The most recent insider transaction was by Baltera Robert Jr. (director), who purchased $88.7K worth of shares on Jul 10, 2026. Palisade Bio, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $342.0M.

PALI Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 10, 2026	Baltera Robert Jr.	director	Buy	45,000	$1.97	$88.7K	461,904
Jul 8, 2026	Finley John David	director, officer: CEO, CFO	Sell	146,798	$2.07	$303.3K	217,555-40%
Jul 8, 2026	Baltera Robert Jr.	director	Buy	50,000	$2.04	$102.1K	416,904
Jul 8, 2026	Jones Mitchell Lawrence	officer: Chief Medical Officer	Sell	51,880	$2.05	$106.5K	94,009-36%
Jul 6, 2026	Baltera Robert Jr.	director	Buy	30,000	$1.98	$59.4K	366,904
Feb 11, 2026	Finley John David	CEO, CFO	Sell	3,896	$1.75	$6.8K	0
Feb 11, 2026	Jones Mitchell Lawrence	Chief Medical Officer	Sell	1,989	$1.75	$3.5K	0
Jan 21, 2026	Williams Donald Allen	director	Buy	5,000	$1.67	$8.4K	10,728+87%
Jan 16, 2026	Williams Donald Allen	Director	Buy	5,000	$1.67	$8.4K	0
Jan 9, 2026	Williams Donald Allen	Director	Buy	5,000	$1.88	$9.4K	0
May 28, 2024	Finley John David	CEO, CFO, Director	Buy	1,000	$4.81	$4.8K	8,437
Feb 7, 2024	Finley John David	CEO, CFO, Director	Buy	10,000	$0.47	$4.7K	84,649
Feb 1, 2024	Finley John David	CEO, CFO, Director	Buy	10,000	$0.56	$5.6K	74,649
Feb 1, 2024	Williams Donald Allen	Director	Buy	10,000	$0.61	$6.0K	30,000+50%
Sep 29, 2023	Finley John David	CEO, CFO, Director	Buy	15,000	$0.54	$8.1K	43,394+53%
Sep 29, 2023	Williams Donald Allen	Director	Buy	20,000	$0.54	$10.8K	20,000
Sep 15, 2023	Trenschel Robert J.	Director	Sell	300	$0.64	$192.00	0Exit
Sep 14, 2023	Finley John David	CEO, CFO, Director	Buy	15,000	$0.66	$9.8K	28,394+112%
Sep 2, 2022	Finley John David	Chief Financial Officer	Buy	19,481	$0.14	$2.8K	148,727
Aug 25, 2022	Finley John David	Chief Financial Officer	Buy	7,350	$0.16	$1.2K	129,246
Aug 18, 2022	Finley John David	Chief Financial Officer	Buy	100,000	$0.25	$25.0K	121,896+457%
Aug 18, 2022	Hallam Thomas	Chief Executive Officer	Buy	40,000	$0.25	$10.0K	57,592+227%
Mar 31, 2022	Dawson Michael John	Chief Medical Officer	Buy	15,000	$1.14	$17.1K	15,000
Mar 29, 2022	Hallam Thomas	Chief Executive Officer	Buy	10,000	$1.18	$11.8K	17,592+132%
Mar 25, 2022	Finley John David	Chief Financial Officer	Buy	7,500	$1.09	$8.2K	21,896+52%
Sep 22, 2021	Finley John David	Chief Financial Officer	Buy	2,000	$2.44	$4.9K	14,396
Sep 22, 2021	Hallam Thomas	Chief Executive Officer	Buy	6,000	$2.49	$14.9K	7,592+377%
Sep 13, 2021	Trenschel Robert J.	Director	Buy	14,999	$2.82	$42.3K	14,999
Aug 30, 2021	Finley John David	Chief Financial Officer	Buy	10,000	$2.65	$26.5K	12,396+417%

PALI Insider Buying Activity

The following table shows recent insider purchases of Palisade Bio, Inc. (PALI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 10, 2026	Baltera Robert Jr.	director	Buy	45,000	$1.97	$88.7K	461,904
Jul 8, 2026	Baltera Robert Jr.	director	Buy	50,000	$2.04	$102.1K	416,904
Jul 6, 2026	Baltera Robert Jr.	director	Buy	30,000	$1.98	$59.4K	366,904
Jan 21, 2026	Williams Donald Allen	director	Buy	5,000	$1.67	$8.4K	10,728+87%
Jan 16, 2026	Williams Donald Allen	Director	Buy	5,000	$1.67	$8.4K	0
Jan 9, 2026	Williams Donald Allen	Director	Buy	5,000	$1.88	$9.4K	0
May 28, 2024	Finley John David	CEO, CFO, Director	Buy	1,000	$4.81	$4.8K	8,437
Feb 7, 2024	Finley John David	CEO, CFO, Director	Buy	10,000	$0.47	$4.7K	84,649
Feb 1, 2024	Finley John David	CEO, CFO, Director	Buy	10,000	$0.56	$5.6K	74,649
Feb 1, 2024	Williams Donald Allen	Director	Buy	10,000	$0.61	$6.0K	30,000+50%
Sep 29, 2023	Finley John David	CEO, CFO, Director	Buy	15,000	$0.54	$8.1K	43,394+53%
Sep 29, 2023	Williams Donald Allen	Director	Buy	20,000	$0.54	$10.8K	20,000
Sep 14, 2023	Finley John David	CEO, CFO, Director	Buy	15,000	$0.66	$9.8K	28,394+112%
Sep 2, 2022	Finley John David	Chief Financial Officer	Buy	19,481	$0.14	$2.8K	148,727
Aug 25, 2022	Finley John David	Chief Financial Officer	Buy	7,350	$0.16	$1.2K	129,246
Aug 18, 2022	Finley John David	Chief Financial Officer	Buy	100,000	$0.25	$25.0K	121,896+457%
Aug 18, 2022	Hallam Thomas	Chief Executive Officer	Buy	40,000	$0.25	$10.0K	57,592+227%
Mar 31, 2022	Dawson Michael John	Chief Medical Officer	Buy	15,000	$1.14	$17.1K	15,000
Mar 29, 2022	Hallam Thomas	Chief Executive Officer	Buy	10,000	$1.18	$11.8K	17,592+132%
Mar 25, 2022	Finley John David	Chief Financial Officer	Buy	7,500	$1.09	$8.2K	21,896+52%
Sep 22, 2021	Finley John David	Chief Financial Officer	Buy	2,000	$2.44	$4.9K	14,396
Sep 22, 2021	Hallam Thomas	Chief Executive Officer	Buy	6,000	$2.49	$14.9K	7,592+377%
Sep 13, 2021	Trenschel Robert J.	Director	Buy	14,999	$2.82	$42.3K	14,999
Aug 30, 2021	Finley John David	Chief Financial Officer	Buy	10,000	$2.65	$26.5K	12,396+417%

PALI Insider Selling Activity

The following table shows recent insider sales of Palisade Bio, Inc. (PALI) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 8, 2026	Finley John David	director, officer: CEO, CFO	Sell	146,798	$2.07	$303.3K	217,555-40%
Jul 8, 2026	Jones Mitchell Lawrence	officer: Chief Medical Officer	Sell	51,880	$2.05	$106.5K	94,009-36%
Feb 11, 2026	Finley John David	CEO, CFO	Sell	3,896	$1.75	$6.8K	0
Feb 11, 2026	Jones Mitchell Lawrence	Chief Medical Officer	Sell	1,989	$1.75	$3.5K	0
Sep 15, 2023	Trenschel Robert J.	Director	Sell	300	$0.64	$192.00	0Exit